| Name | 5-Hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl 6-deoxy-α-L-mannopyranosyl-(1->2)-[6-deoxy-α-L-mannopyranosyl-(1->6)]-β-D-glucopyranoside |
|---|---|
| Synonyms |
5-Hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl 6-deoxy-α-L-mannopyranosyl-(1->2)-[6-deoxy-α-L-mannopyranosyl-(1->6)]-β-D-glucopyranoside
ligustroflavone 4H-1-Benzopyran-4-one, 7-[[O-6-deoxy-α-L-mannopyranosyl-(1->2)-O-[6-deoxy-α-L-mannopyranosyl-(1->6)]-β-D-glucopyranosyl]oxy]-5-hydroxy-2-(4-hydroxyphenyl)- |
| Description | Ligustroflavone, extracted from Ligustrum lucidum, is a potential candidate as calcium-sensing receptor (CaSR) antagonist. Ligustroflavone exhibits protective effects against diabetic osteoporosis in mice[1]. |
|---|---|
| Related Catalog | |
| Target |
CaSR[1]. |
| References |
| Density | 1.7±0.1 g/cm3 |
|---|---|
| Boiling Point | 1028.5±65.0 °C at 760 mmHg |
| Molecular Formula | C33H40O18 |
| Molecular Weight | 724.66 |
| Flash Point | 325.2±27.8 °C |
| Exact Mass | 724.221436 |
| PSA | 287.89000 |
| LogP | 1.56 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.714 |
| Safety Phrases | 24/25 |
|---|